av/bright-minds-biosciences--big.svg

NASDAQ:DRUG

Bright Minds Biosciences Inc.

  • Stock

USD

Last Close

1.45

23/07 17:48

Market Cap

6.12M

Beta: 1.25

PE Ratio

−1.30

PFCF: −1.69

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
net income
-78.72K
-
-480.38K
510.26%
-8.65M
1,700.83%
-14.96M
72.99%
-7.37M
50.74%
depreciation and amortization
6.04K
-
72.45K
1,100.10%
deferred income tax
45.35K
-
stock based compensation
161.30K
-
880.62K
445.95%
875.06K
0.63%
1.15M
31.66%
change in working capital
36.71K
-
30.68K
16.41%
306.08K
897.50%
726.31K
137.29%
-941.72K
229.66%
accounts receivables
-110.15K
-
-45.63K
58.57%
118.80K
360.33%
inventory
accounts payables
other working capital
36.71K
-
30.68K
16.41%
416.23K
1,256.46%
771.94K
85.46%
-1.06M
237.38%
other non cash items
144.76K
-
-229.57K
258.59%
19.75K
108.60%
net cash provided by operating activities
-42.01K
-
-288.39K
586.50%
-7.32M
2,437.97%
-13.59M
85.63%
-7.02M
48.30%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
-7.16K
-
-86.11K
1,102.35%
common stock issued
122K
-
1.01M
726.50%
27.74M
2,651.56%
4.03M
85.46%
1.22M
69.83%
common stock repurchased
dividends paid
other financing activites
366
-
1.01K
175.50%
-1.69M
167,627.10%
1.17M
169.17%
1.06M
9.43%
net cash used provided by financing activities
122K
-
1.01M
726.50%
26.06M
2,484.03%
5.20M
80.06%
2.19M
57.86%
effect of forex changes on cash
223.79K
-
258.82K
15.66%
-45.35K
117.52%
net change in cash
79.99K
-
719.94K
800.02%
18.96M
2,533.57%
-8.13M
142.89%
-4.88M
39.99%
cash at beginning of period
79.99K
-
799.93K
900.02%
19.76M
2,370.22%
11.63M
41.15%
cash at end of period
79.99K
-
799.93K
900.02%
19.76M
2,370.22%
11.63M
41.15%
6.75M
41.97%
operating cash flow
-42.01K
-
-288.39K
586.50%
-7.32M
2,437.97%
-13.59M
85.63%
-7.02M
48.30%
capital expenditure
free cash flow
-42.01K
-
-288.39K
586.50%
-7.32M
2,437.97%
-13.59M
85.63%
-7.02M
48.30%

All numbers in USD (except ratios and percentages)